RT Journal Article
SR Electronic
T1 COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A System for Predicting Mortality of Patients with COVID-19 Pneumonia at the Time They Require Mechanical Ventilation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.09.22268977
DO 10.1101/2022.01.09.22268977
A1 Raschke, Robert A
A1 Rangan, Pooja
A1 Agarwal, Sumit
A1 Uppalapu, Suresh
A1 Sher, Nehan
A1 Curry, Steven C
A1 Heise, C. William
YR 2022
UL http://medrxiv.org/content/early/2022/01/11/2022.01.09.22268977.abstract
AB Background An accurate system to predict mortality in patients requiring intubation for COVID-19 could help to inform consent, frame family expectations and assist end-of-life decisions.Research objective To develop and validate a mortality prediction system called C-TIME (COVID-19 Time of Intubation Mortality Evaluation) using variables available before intubation, determine its discriminant accuracy, and compare it to APACHE IVa and SOFA.Methods A retrospective cohort was set in 18 medical-surgical ICUs, enrolling consecutive adults, positive by SARS-CoV 2 RNA by reverse transcriptase polymerase chain reaction or positive rapid antigen test, and undergoing endotracheal intubation. All were followed until hospital discharge or death. The combined outcome was hospital mortality or terminal extubation with hospice discharge. Twenty-five clinical and laboratory variables available 48 hours prior to intubation were entered into multiple logistic regression (MLR) and the resulting model was used to predict mortality of validation cohort patients. AUROC was calculated for C-TIME, APACHE IVa and SOFA.Results The median age of the 2,440 study patients was 66 years; 61.6 percent were men, and 50.5 percent were Hispanic, Native American or African American. Age, gender, COPD, minimum mean arterial pressure, Glasgow Coma scale score, and PaO2/FiO2 ratio, maximum creatinine and bilirubin, receiving factor Xa inhibitors, days receiving non-invasive respiratory support and days receiving corticosteroids prior to intubation were significantly associated with the outcome variable. The validation cohort comprised 1,179 patients. C-TIME had the highest AUROC of 0.75 (95%CI 0.72-0.79), vs 0.67 (0.64-0.71) and 0.59 (0.55-0.62) for APACHE and SOFA, respectively (Chi2 P<0.0001).Conclusions C-TIME is the only mortality prediction score specifically developed and validated for COVID-19 patients who require mechanical ventilation. It has acceptable discriminant accuracy and goodness-of-fit to assist decision-making just prior to intubation. The C-TIME mortality prediction calculator can be freely accessed on-line at https://phoenixmed.arizona.edu/ctime.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded in part by a grant (#2196) from the Flinn foundation - the foundation had no direct role however in formulating the research objective, methodology, data collection, analysis, manuscript preparation or decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Arizona College of Medicine IRB approved the study on 4/21/2021. the approval document number is 2004567016I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAPACHEacute physiology and chronic health evaluationAUROCarea under the receiver-operating curveBMIbody mass indexCOPDchronic obstructive pulmonary diseaseCOVID-19coronavirus disease 2019C-TIMECOVID-19 time of intubation mortality evaluationFiO2fraction of inspired oxygenMLRmultiple logistic regressionPaO2partial pressure of arterial oxygenSARS CoV-2severe acute respiratory syndrome coronavirus 2SOFAsequential organ failure assessment